Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma | Zendy

Rajappa S. Kenchappa | Zendy; Athanassios Dovas | Zendy; Michael Argenziano | Zendy; Christian T. Meyer | Zendy; Lauren Stopfer | Zendy; Matei A. Banu | Zendy; Brianna Pereira | Zendy; Jessica I. Griffith | Zendy; Afroz S. Mohammad | Zendy; Surabhi Talele | Zendy; Ashley Haddock | Zendy; Natanael Zarco | Zendy; William F. Elmquist | Zendy; Forest M. White | Zendy; Vito Quaranta | Zendy; Peter A. Sims | Zendy; Peter Canoll | Zendy; Steven S. Rosenfeld | Zendy

Open Access

Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma

Author(s) -

Rajappa S. Kenchappa,

Athanassios Dovas,

Michael Argenziano,

Christian T. Meyer,

Lauren Stopfer,

Matei A. Banu,

Brianna Pereira,

Jessica I. Griffith,

Afroz S. Mohammad,

Surabhi Talele,

Ashley Haddock,

Natanael Zarco,

William F. Elmquist,

Forest M. White,

Vito Quaranta,

Peter A. Sims,

Peter Canoll,

Steven S. Rosenfeld

Publication year - 2022

Publication title -

cell reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.264

H-Index - 154

eISSN - 2639-1856

pISSN - 2211-1247

DOI - 10.1016/j.celrep.2022.110991

Subject(s) - mitosis , cancer research , proto oncogene tyrosine protein kinase src , kinesin , stat3 , microtubule , signal transduction , egfr inhibitors , epidermal growth factor receptor , kinase , microbiology and biotechnology , biology , cancer , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research